Europe Breast Lesion Localization Methods Market: By Technology (Radio Isotope Localization (Radio Isotope Seed Localization (RSL), Radio Occult Lesion Localization (ROLL), Others), Wire Guided localization, Magnetic Tracker, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASC’s), and Others), and Country  

Purchase Option

$ 3100
$ 4600
$ 6900

Europe Breast Lesion Localization Methods market size is valued at USD 265.2 million in 2023 and is expected to grow at a CAGR of 4.9% during the forecast period 2024 to 2030. The European market provides a detailed overview of the Europe Breast Lesion Localization Methods market, and that can be segmented by drug Technology, by end user, and by application. By drug Technology, The Europe Breast Lesion Localization Methods market has been segmented into Radio Isotope Localization (RIL), Radio Isotope Seed Localization (RSL), Radio Occult Lesion Localization (ROLL), Others), Wire Guided localization, Magnetic Tracker, Others. The Platelet – Rich Plasma segment is likely to be the largest and fastest-growing segment in terms of drug Technology. The supremacy of this segment is owing to the application of platelet-rich plasma therapy in bone degeneration disease. It was found that platelet-rich plasma therapy for curing knee osteoarthritis has a high success rate and the efficiency depends on the brutality of knee osteoarthritis. However, Cortisone or steroids is projected to grow with the fastest CAGR during the forecast period. It is mainly because corticosteroid injections can cure various spinal conditions and skeletal, and muscular. Dexamethasone, prednisone, methylprednisolone, and hydrocortisone are FDA-approved corticosteroid injections utilized to decrease inflammation and pain.

Such characteristics of corticosteroid injections and their need for numerous bone diseases and injuries fuel the growth of the Bone Degeneration Therapeutics Market Share. Based on the End user, the Europe Breast Lesion Localization Methods market is segmented into Hospitals, Ambulatory Surgical Centers (ASC’s), and Others. Among these, the Parenteral segment is expected to have a significant growing market during the forecast period 2022-2028. Based on the Application, the Europe Breast Lesion Localization Methods market is segmented into Osteopenia, Osteoarthritis, and Spinal Fusion. The Osteoarthritis segment accounts for the largest share in 2021. Based on the distribution channel, the Europe Breast Lesion Localization Methods market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Homecare Settings. The Hospital Pharmacies segment accounts for the largest share in 2021.

Europe Breast Lesion Localization Methods market Key Developments:

In August 2021, CTI Biopharma Corporation and DRI Healthcare Trust announced the funding of pacrinitib sales and subsequent product approval by the US Food and Drug Administration (FDA). In October 2019, Amgen acquired Teneobio, Inc

Europe Breast Lesion Localization Methods Market Dynamics

The supremacy of this segment is owing to the application of platelet-rich plasma therapy in bone degeneration disease. It was found that platelet-rich plasma therapy for curing knee osteoarthritis has a high success rate and the efficiency depends on the brutality of knee osteoarthritis. However, Cortisone or steroids is projected to grow with the fastest CAGR during the forecast period. It is mainly because corticosteroid injections can cure various spinal conditions and skeletal, and muscular. Dexamethasone, prednisone, methylprednisolone, and hydrocortisone are FDA-approved corticosteroid injections utilized to decrease inflammation and pain. Such characteristics of corticosteroid injections and their need for numerous bone diseases and injuries fuel the growth of the Bone Degeneration Therapeutics Market Share. Based on the End user, the Europe Breast Lesion Localization Methods market is segmented into Hospitals, Ambulatory Surgical Centers (ASC’s), and Others.

Key Features of the Reports

  • The europe breast lesion localization methods market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Europe Breast Lesion Localization Methods Market Segmentation

By Drug Technology
  • Radio Isotope Localization (RIL)
  • Radio Isotope Seed Localization (RSL)
  • Radio Occult Lesion Localization (ROLL)
  • Others
By End-user
  • Hospitals
  • Ambulatory Surgical Centers (ASC’s)
  • Others
By Application
  • Osteopenia
  • Osteoarthritis
  • Spinal Fusion
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Homecare Settings

Frequently Asked Questions

The Europe Breast Lesion Localization Methods Market market size was valued at USD 265.2 million in 2023 and is expected to grow at a CAGR of 4.9% during the forecast period 2024 to 2030

The key players of Europe Breast Lesion Localization Methods Market are Cianna Medical, Inc. (U.S.), STERYLAB (Italy), Cook Group Inc. (U.S.), SOMATEX Medical Technologies GmbH (Germany), CP Medical, Inc. (Theragenics Corporation) (U.S.), R. Bard, Inc. (U.S.), Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.), Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.), Endomag (UK)

The Europe Breast Lesion Localization Methods Market data: Europe (Germany, France, Italy, Spain, and United Kingdom (UK)

1.Executive Summary
2. Europe Breast Lesion Localization Methods Market Introduction 
2.1. Europe Breast Lesion Localization Methods Market  - Taxonomy
2.2. Europe Breast Lesion Localization Methods Market  - Definitions
2.2.1.Drug Technology
2.2.2.End-user
2.2.3.Application
2.2.4.Distribution Channel
2.2.5.Country
3. Europe Breast Lesion Localization Methods Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Europe Breast Lesion Localization Methods Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Europe Breast Lesion Localization Methods Market  By Drug Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Radio Isotope Localization (RIL)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Radio Isotope Seed Localization (RSL)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Radio Occult Lesion Localization (ROLL)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Europe Breast Lesion Localization Methods Market  By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ambulatory Surgical Centers (ASC’s)
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Europe Breast Lesion Localization Methods Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Osteopenia
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Osteoarthritis
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Spinal Fusion
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Europe Breast Lesion Localization Methods Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Homecare Settings
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Europe Breast Lesion Localization Methods Market  By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Europe
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. France
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Germany
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Italy
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. United Kingdom (UK)
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Spain
9.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Europe Europe Breast Lesion Localization Methods Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Radio Isotope Localization (RIL)
10.1.2.Radio Isotope Seed Localization (RSL)
10.1.3.Radio Occult Lesion Localization (ROLL)
10.1.4.Others
10.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Ambulatory Surgical Centers (ASC’s)
10.2.3.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Osteopenia
10.3.2.Osteoarthritis
10.3.3.Spinal Fusion
10.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacies
10.4.4.Homecare Settings
11.France Europe Breast Lesion Localization Methods Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Radio Isotope Localization (RIL)
11.1.2.Radio Isotope Seed Localization (RSL)
11.1.3.Radio Occult Lesion Localization (ROLL)
11.1.4.Others
11.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Ambulatory Surgical Centers (ASC’s)
11.2.3.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Osteopenia
11.3.2.Osteoarthritis
11.3.3.Spinal Fusion
11.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacies
11.4.4.Homecare Settings
12.Germany Europe Breast Lesion Localization Methods Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Radio Isotope Localization (RIL)
12.1.2.Radio Isotope Seed Localization (RSL)
12.1.3.Radio Occult Lesion Localization (ROLL)
12.1.4.Others
12.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Ambulatory Surgical Centers (ASC’s)
12.2.3.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Osteopenia
12.3.2.Osteoarthritis
12.3.3.Spinal Fusion
12.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacies
12.4.4.Homecare Settings
13.Italy Europe Breast Lesion Localization Methods Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Radio Isotope Localization (RIL)
13.1.2.Radio Isotope Seed Localization (RSL)
13.1.3.Radio Occult Lesion Localization (ROLL)
13.1.4.Others
13.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Hospitals
13.2.2.Ambulatory Surgical Centers (ASC’s)
13.2.3.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Osteopenia
13.3.2.Osteoarthritis
13.3.3.Spinal Fusion
13.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacies
13.4.4.Homecare Settings
14.United Kingdom (UK) Europe Breast Lesion Localization Methods Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Radio Isotope Localization (RIL)
14.1.2.Radio Isotope Seed Localization (RSL)
14.1.3.Radio Occult Lesion Localization (ROLL)
14.1.4.Others
14.2.  End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Hospitals
14.2.2.Ambulatory Surgical Centers (ASC’s)
14.2.3.Others
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Osteopenia
14.3.2.Osteoarthritis
14.3.3.Spinal Fusion
14.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacies
14.4.4.Homecare Settings
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Cianna Medical, Inc. 
15.2.2.STERYLAB 
15.2.3.Cook Group Inc. 
15.2.4.SOMATEX Medical Technologies GmbH 
15.2.5.CP Medical, Inc. (Theragenics Corporation) 
15.2.6.R. Bard, Inc.
15.2.7.Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) 
15.2.8.Faxitron, Inc. (Faxitron Bioptics, LLC) 
15.2.9.Endomag 
16. Research Methodology 
17. Appendix and Abbreviations 
  • Cianna Medical, Inc. 
  • STERYLAB 
  • Cook Group Inc. 
  • SOMATEX Medical Technologies GmbH 
  • CP Medical, Inc. (Theragenics Corporation) 
  • R. Bard, Inc.
  • Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) 
  • Faxitron, Inc. (Faxitron Bioptics, LLC) 
  • Endomag 

Adjacent Markets